Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
USOTC
Axim Biotechnologies Inc (QB) (AXIM)
Axim Biotechnologies Inc (QB) (AXIM) News

AXIM

Axim Biotechnologies (QB) (AXIM)

Axim Biotechnologies Inc (QB)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:AXIM

<< Previous 1 2 3 4 5 6 7 Next >>

Date	Time	Source	Headline	Symbol	Company
05/11/2018	5:24PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
04/18/2018	4:47PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
04/18/2018	4:45PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
04/06/2018	3:36PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
04/05/2018	5:21PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
03/15/2018	5:06PM	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
12/13/2017	8:45AM	InvestorWire	Dangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic Pain	USOTC:AXIM	Axim Biotechnologies Inc (QB)
12/06/2017	8:45AM	InvestorWire	Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management	USOTC:AXIM	Axim Biotechnologies Inc (QB)
11/20/2017	12:47PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
11/15/2017	6:03AM	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
11/07/2017	8:45AM	InvestorWire	Biotech M&A Momentum Attractive for Cannabinoid R&D Space	USOTC:AXIM	Axim Biotechnologies Inc (QB)
10/25/2017	8:45AM	InvestorWire	Biotechs Develop Proprietary Systems to Drive CBD Research and Development	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/28/2017	8:45AM	InvestorWire	Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/26/2017	8:45AM	InvestorWire	Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/15/2017	6:02AM	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/14/2017	11:26AM	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/14/2017	11:22AM	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/14/2017	11:19AM	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
09/13/2017	8:45AM	InvestorWire	Biosynthesis Technology Could Transform Cannabinoid Production	USOTC:AXIM	Axim Biotechnologies Inc (QB)
08/24/2017	5:18PM	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
08/21/2017	3:25PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
08/14/2017	2:10PM	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
07/27/2017	8:45AM	InvestorWire	Biotech Players Lead the Growth Charge in the Legal Cannabis Market	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/26/2017	6:02AM	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/23/2017	6:09PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/23/2017	6:07PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/23/2017	6:05PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/23/2017	6:01PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/23/2017	5:58PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AXIM	Axim Biotechnologies Inc (QB)
06/16/2017	5:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AXIM	Axim Biotechnologies Inc (QB)

Showing the most relevant articles for your search:USOTC:AXIM

<< Previous 1 2 3 4 5 6 7 Next >>

Marketing Worldwide (PK)

Bell Buckle (PK)

Seafarer Exploration (PK)

Virexit Technologies (PK)

NioCorp Developments

Canopus Biopharma (PK)

Brookmount Explorations (PK)

Therapeutic Solutions (PK)

Seven Arts Entertainment (PK)

Fannie Mae (QB)

Decentral Life (PK)

Anavex Life Sciences

Ubiquitech Software (PK)

Delayed Upgrade Clock